Keyword Analysis & Research: keynote 028 mesothelioma

Keyword Analysis



Keyword Research: People who searched keynote 028 mesothelioma also searched

Frequently Asked Questions

What is the best treatment for mesothelioma?

Mesothelioma and Keytruda. Keytruda is an immunotherapy drug that uses a patient’s own immune system to attack and kill cancer cells. The therapy is currently in clinical trials to test its efficacy as a mesothelioma cancer treatment.

What is the keynote-028 clinical trial?

The clinical trial is called KEYNOTE-028 and involved thirteen research teams in six different countries. The trial included twenty-five patients with pleural mesothelioma who had already received at least one chemotherapy treatment before the trial. Patients received a larger than normal dose of pembrolizumab every two weeks.

How successful is Keytruda® for mesothelioma?

The KEYNOTE-028 clinical trial conducted in 13 different sites across six different countries was the first to show success using Keytruda® to treat malignant pleural mesothelioma patients who were previously treated with chemotherapy or were considered ineligible for treatment.

What are the NCCN guidelines for malignant pleural mesothelioma?

Keytruda® has now been included as a recommended therapy option in the National Comprehensive Cancer Network (NCCN) malignant pleural mesothelioma guidelines, meaning that patients can now receive immunotherapy drugs as a standard treatment option outside of a clinical trial.


Search Results related to keynote 028 mesothelioma on Search Engine